cyclopentane has been researched along with Anochlesia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amalric, M; Brotchie, JM; Johnston, TH; Lopez, S; Neuville, P; Schann, S; Turle-Lorenzo, N | 1 |
| Alam, M; Danysz, W; Dekundy, A; Schmidt, WJ | 1 |
| Froestl, W; Kusek, M; Pilc, A; Tokarski, K; Wabno, J; Wierońska, JM | 1 |
| Bednar, RA; Cunningham, ME; Dilella, AG; Fandozzi, C; Fay, JF; Kelly, MJ; Koblan, KS; Layton, ME; Liang, A; Lis, EV; McDonald, TP; Mosser, SD; Reiss, DR; Rodzinak, KJ; Sanderson, PE; Seabrook, GR; Trainor, N; Urban, MO; Wang, H; Yergey, J; Young, SD | 1 |
| Dagaev, SG; Dolgo-Saburov, VB; Fil'ko, OA; Glukhova, RI; Khrabrova, AV; Kubarskaya, LG; Mukovskii, LA; Sanotskii, VI | 1 |
| Danysz, W; Karcz-Kubicha, M; Lorenz, B | 1 |
| Hattori, F; Inoue, N; Matsui, A; Matsuo, H; Nasu, R; Ohtani, H; Sawada, Y; Takanaga, H | 1 |
| Andén, NE; Bédard, P | 1 |
8 other study(ies) available for cyclopentane and Anochlesia
| Article | Year |
|---|---|
Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats.
Topics: Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Catalepsy; Cyclopentanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Haloperidol; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pyridines; Rats; Rats, Wistar; Reaction Time; Receptors, Adenosine A2; Receptors, Metabotropic Glutamate; Tricarboxylic Acids; Xanthines | 2008 |
Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Basal Ganglia; Behavior, Animal; Catalepsy; Cyclopentanes; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Hypokinesia; Idazoxan; Male; Motor Activity; Muscle Rigidity; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinsonian Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Adrenergic, alpha-2; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Rotenone; Serotonin; Substantia Nigra; Time Factors | 2009 |
The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.
Topics: Animals; Behavior, Animal; Catalepsy; Cyclopentanes; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Frontal Lobe; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Hyperkinesis; Male; Mice; Motor Activity; Phosphinic Acids; Psychoses, Substance-Induced; Pyrimidines; Receptors, GABA-B; Syndrome | 2011 |
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonists.
Topics: Administration, Oral; Animals; Benzopyrans; Biological Availability; Catalepsy; Cyclopentanes; Dogs; Drug Discovery; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Excitatory Amino Acid Antagonists; Female; Half-Life; Indicators and Reagents; Isomerism; Ligation; Macaca mulatta; Male; Neuralgia; Oxadiazoles; Parkinson Disease; Piperidines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Nerves | 2011 |
Effect of M2 muscarinic receptor blockade in rats with haloperidol-produced catatonic syndrome.
Topics: Animals; Catalepsy; Cyclopentanes; Diamines; Dopamine; Haloperidol; Male; Mandelic Acids; Muscarinic Antagonists; Piperidines; Receptor, Muscarinic M2; Syndrome; Trihexyphenidyl | 2004 |
GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist.
Topics: Animals; Antiparkinson Agents; Binding, Competitive; Catalepsy; Cyclopentanes; Drug Evaluation, Preclinical; Drug Synergism; Excitatory Amino Acid Antagonists; Glycine Agents; Haloperidol; Hypnotics and Sedatives; Levodopa; Male; Neuroprotective Agents; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reserpine | 1999 |
Propiverine-induced Parkinsonism: a case report and a pharmacokinetic/pharmacodynamic study in mice.
Topics: Animals; Antitussive Agents; Benzilates; Catalepsy; Cholinergic Antagonists; Cyclopentanes; Male; Mandelic Acids; Mice; Neostriatum; Parkinson Disease, Secondary; Pharmaceutical Solutions; Propafenone; Receptors, Cholinergic; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2000 |
Influences of cholinergic mechanisms on the function and turnover of brain dopamine.
Topics: Animals; Apomorphine; Atropine; Basal Ganglia; Brain; Catalepsy; Cyclopentanes; Dopamine; Hallucinogens; Haloperidol; Humans; Mandelic Acids; Norepinephrine; Parasympatholytics; Piperidines; Rats; Scopolamine; Trihexyphenidyl | 1971 |